by McDermott + Bull | May 23, 2023 | Investor Insights, Ken Dropiewski
McDermott + Bull Partner Ken Dropiewski interviews H.I.G. Capital Managing Director Gwen Watanabe in his series, Investor Insights in Life Sciences + MedTech. In these conversations, they discuss H.I.G. Capital investments and medtech ventures in 2023. SEE MORE...
by McDermott + Bull | Jan 11, 2023 | Investor Insights, Ken Dropiewski
McDermott + Bull Partner Ken Dropiewski interviews Gilde Healthcare General Partner Geoff Pardo in his series, Investor Insights in Life Sciences + MedTech. In the conversations below, Ken and Geoff discuss what venture in MedTech will look like in 2023, what Gilde...
by McDermott + Bull | Nov 16, 2022 | Investor Insights, Ken Dropiewski
McDermott + Bull Partner Ken Dropiewski interviews Endeavour Venture Partner Rob Barmann in his series, Investor Insights in Life Sciences + MedTech. In the conversations below, Ken and Rob discuss a range of topics from typical investment sizes to non-traditional...
by McDermott + Bull | Aug 26, 2022 | Investor Insights, Ken Dropiewski
McDermott + Bull Partner Ken Dropiewski interviews CRG Director Sabir Rassiwalla in his series, Investor Insights in Life Sciences + MedTech. In the conversations below, Ken and Sabir discuss MedTech’s continuously changing landscape, what makes CRG different...
by McDermott + Bull | Mar 1, 2022 | Investor Insights, Ken Dropiewski
This week on Investor Insights, host Ken Dropiewski interviews James Eadie, Managing Director of Santé Ventures. They discuss a number of topics including James’s journey into Santé Ventures, Santé’s portfolio, and the working relationship between Santé...
by McDermott + Bull | Dec 1, 2021 | Investor Insights, Ken Dropiewski
This week on Investor Insights, host Ken Dropiewski interviews Justin Klein, MD, JD and Kirk Nielsen, both Co-Founders and Managing Partners of Vensana Capital. They discuss a number of topics including the future of MedTech, the changes within the industry over the...
